Abstract
Growing evidence from several clinical and experimental studies indicates that arginine and nitric oxide are critical to the normal physiology of the gastrointestinal tract and maintain the mucosal integrity of the intestine in various intestinal disorders such as inflammatory bowel disease, rheumatoid arthritis, and hepatitis. In this report, we discuss the use of a dietary arginine supplementation in the treatment of different gastrointestinal disorders including intestinal ischemia-reperfusion, short bowel syndrome, chemotherapy-induced mucositis, microvillous inclusion disease, etc. The mechanisms of action of arginine and nitric oxide on intestinal cell turnover (proliferation and apoptosis) as well as the effects of this agent on intestinal regrowth after bowel resection and intestinal recovery following intestinal ischemia or chemotherapy-induced damage in rodent models are discussed. Such knowledge may allow us to exploit arginine that acts as gut-trophic agent for the bowel mucosa and suggest new therapeutic strategies to maintain gut integrity after massive bowel resection or intestinal injury, eliminating the dependence on total parenteral nutrition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cynober L, Le Boucher J, Vasson MP. l-Arginine metabolism in mammals. Nutr Biochem. 1995;6:402–13.
Kirk SJ, Barbul A. Role of l-arginine in trauma, sepsis and immunity. JPEN. 1990;14(5 Suppl):226S–9.
Scull CW, Rose WC. l-Arginine metabolism: the relation of the l-arginine content of the diet to the increments in tissue l-arginine during growth. J Biol Chem. 1930;39:109–14.
Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994;14:1199–206.
Cote CG, Yu FS, Zulueta JJ, Vosatka RJ, Hassoun PM. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol. 1996;271:L869–74.
Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun. 2001;282:1075–9.
Potten CS, Nellet M, Roberts SA, Revi RA, Wilson GD. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut. 1992;33:71–8.
Wright N, Alison M. The biology of epithelial cell populations. Oxford: Clarendon; 1984.
Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. I. Evidence from Paneth cells in the adult mouse. Am J Anat. 1981;160:51–63.
Rhoads J, Wu GY. Glutamine, l-arginine, and leucine signaling in the intestine. Amino Acids. 2009;37:111–22.
Rhoads JM, Chen W, Gookin J, Wu GY, Fu Q, Blikslager AT, Rippe RA, Argenzio RA, Cance WG, Weaver EM. l-Arginine stimulates intestinal cell migration through a focal adhesion kinase dependent mechanism. Gut. 2004;53:514–22.
Rhoads M, Fu Q, Rippe R, Odle J, Graves LM. Focal adhesion kinase (FAK) and p70 s6 kinase are critical for l-arginine stimulated intestinal cell migration. J Investig Med. 2004;52:S291–2.
Deitch EA. Multiple organ failure. Ann Surg. 1992;216:117–25.
Lemaire LCJM, van Lanschot JJB, Stoutenbeek CP, van Deventer SJH, Wells CL, Gouma DJ. Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg. 1997;84:1340–5.
Bansal V, Ochoa JB. l-Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003;6:223–9.
Gurbuz AT, Kunzelman J, Ratzer EE. Supplemental dietary l-arginine accelerates intestinal mucosal regeneration and enhances bacterial clearance following radiation enteritis in rats. J Surg Res. 1996;74:149–56.
Schleiffer R, Raul F. Prophylactic administration of l-arginine improves the intestinal barrier function after mesenteric ischemia. Gut. 1996;39:194–9.
Liu Y, Huang JJ, Hou YQ, Zhu HL, Zhao SJ, Ding BY, Yin YL, Yi GF, Shi JX, Fan W. Dietary l-arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br J Nutr. 2008;100:552–60.
Gookin JL, Rhoads JM, Argenzio RA. Inducible nitric oxide synthase mediates early epithelial repair of porcine ileum. Am J Physiol Gastrointest Liver Physiol. 2002;283:G157–63.
Sukhotnik I, Mogilner J, Krausz MM, Lurie M, Hirsh M, Coran AG, Shiloni E. Oral l-arginine reduces gut mucosal injury caused by lipopolysaccharide endotoxemia in rat. J Surg Res. 2004;122:256–62.
Haglund U, Bergqvist D. Intestinal ischemia—the basics. Langenbecks Arch Surg. 1999;384:233–8.
Khanna A, Rossman J, Caty MG, Fung HL. Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats. J Surg Res. 2003;114:15–24.
Granger DN, Hollwarth ME, Park DA. Ischemia reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand Suppl. 1986;548:47–56.
Terada LS, Mahr NN, Jacobson ED. Nitric oxide decreases lung injury after intestinal ischemia. J Appl Physiol. 1996;81:2456–60.
Luo CC, Chen HM, Chiu CH, Lin JN, Chen JC. Effect of N-nitro-l-arginine methyl ester on intestinal permeability following intestinal ischemia-reperfusion injury in a rat model. Biol Neonate. 2001;80:60–3.
Ward DT, Lawson SA, Gallagher CM, Conner WC, Shea-Donohue T. Sustained nitric oxide production via l-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J Surg Res. 2000;89:13–9.
Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Botelho LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 1991;181:1392–7.
Kubes P, Suzuki M, Granger DN. Nitric oxide. An endogenous modulator of leukocyte adhesions. Proc Natl Acad Sci USA. 1991;88:4651–7.
Sukhotnik I, Helou H, Mogilner J, Lurie M, Bernsteyn A, Coran AG, Shiloni E. Oral l-arginine improves intestinal recovery following ischemia-reperfusion injury in rat. Pediatr Surg Int. 2005;21:191–6.
Naidu MUR, Ramana GV, Rani PU. Chemotherapy-induced and/or radiation therapy-induced oral mucositis? Complicating the treatment of cancer. Neoplasia. 2004;6:423–31.
Sonis ST. Complications of cancer and their treatment: oral complications. In: Holland JF, Frei E, Bast RC, editors. Cancer medicine. 3rd ed. Philadelphia: Lea and Febiger; 1993. p. 2381–8.
Sonis ST, Elting LS, Keefe DMK, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:1995–2025.
Hämäläinen M, Lahti A, Moilanen E. Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines. Eur J Pharmacol. 2002;448:239–44.
Gulgun M, Karaoglu A, Kesik V. Effect of proanthocyanidin, l-arginine and glutamine supplementation on methotrexate-induced gastrointestinal toxicity in rats. Methods Find Exp Clin Pharmacol. 2010;32:657–61.
Izaola O, de Luis DA, Cuellar L. Influence of an immuno-enhanced formula in postsurgical ambulatory patients with head and neck cancer. Nutr Hosp. 2010;25:793–6.
Koppelmann T, Pollak Y, Mogilner J, Bejar J, Coran AG, Sukhotnik I. Dietary l-arginine supplementation reduces methotrexate-induced intestinal mucosal injury in rat. BMC Gastroenterol. 2012;12:41–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sukhotnik, I. (2017). Dietary l-Arginine and Intestinal Recovery. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-26009-9_27
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-26007-5
Online ISBN: 978-3-319-26009-9
eBook Packages: MedicineMedicine (R0)